How I treat HHV8/KSHV-related diseases in posttransplant patients
- 15 November 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (20) , 4150-4159
Abstract
Posttransplantation human herpesvirus-8 (HHV8)/Kaposi sarcoma herpesvirus (KSHV) primary infection and/or reactivations are associated with uncommon and sometimes fatal, neoplastic, and non-neoplastic diseases. HHV8-related clinical manifestations notably range from Kaposi sarcoma (KS) to either primary effusion lymphoma or multicentric Castleman disease B-cell malignancies, and from polyclonal HHV8-positive plasmacytic lymphoproliferative disorders to bone marrow failure and peripheral cytopenias, associated or not with hemophagocytic syndromes, and to acute hepatitis syndromes. We reviewed the patient series reported in the literature and summarized clinical management aspects, in terms of diagnosis, follow-up, and treatment. We described typical clinical presentations and histopathologic diagnostic features of these diseases, and we discussed the role of HHV8-specific serologic, molecular, and immunologic assays, particularly focusing on recent data from HHV8-specific T-cell monitoring in posttransplantation KS patients. We finally discussed actual therapeutic options, namely, the reduction or discontinuation of immunosuppressive therapy or the switch from calcineurin inhibitors to mTOR inhibitors, as alternatives to antineoplastic chemotherapy, along with the use of antiherpesvirus agents as prophylactic or therapeutic measures, and treatment with rituximab in posttrans-plantation multicentric Castleman disease patients and non-neoplastic HHV8-associated syndromes.Keywords
This publication has 93 references indexed in Scilit:
- Electrochemotherapy in the Treatment of Kaposi Sarcoma Cutaneous Lesions: A Two-Center Prospective Phase II TrialAnnals of Surgical Oncology, 2011
- Visceral Kaposi's Sarcoma Remission After Intestinal Transplant. First Case Report and Systematic Literature ReviewTransplantation, 2010
- How I treat EBV lymphoproliferationBlood, 2009
- Valganciclovir for Suppression of Human Herpesvirus–8 Replication: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover TrialThe Journal of Infectious Diseases, 2008
- Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8–specific CD8+ T cellsBlood, 2008
- Kaposi's sarcoma after allogeneic peripheral blood stem cell transplantationInternational Journal of Dermatology, 2003
- Transmission of Human Herpesvirus 8 Infection from Renal-Transplant Donors to RecipientsNew England Journal of Medicine, 1998
- KS-associated herpesvirus-like DNA sequences after allogeneic bone-marrow transplantationThe Lancet, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Kaposi's Sarcoma in a child after autologous bone marrow transplantation for non-Hodgkin's lymphomaCancer, 1991